While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

BAYRY secures first global approval for Lynkuet in the UK, a hormone-free treatment for menopause-related hot flashes.

Menopausal hormonal therapy, including estrogen alone and estrogen combined with progesterone, has been prescribed to help with those symptoms for decades. Hormones were also used to treat the ...

Bayer said it received approval in the U.K. to use elinzanetant for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes, linked with menopause.

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Women in midlife face a difficult trade-off. Many in their 40s to 60s face a high risk of breast cancer, especially during ...

O f all the changes that accompany perimenopause and menopause, hot flashes are among the most common-and the most bothersome ...

Hot flashes are a menopausal hallmark: Up to 80 percent of women have them. But numerous lesser-known symptoms are also ...